Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2011-09-23
Product name
Flunixin Meglumine Solution
Product Synonyms
Flunixin Meglumine Solution Banamine Injectable Solution Finadyne Injectable Solution Finixin Solution Bedozane Solution
Emergency telephone
(800) 424-9300, (703) 527-3887
Icons in SDS
Company Information
company name
MERCK
Section 2
SECTION 2: Hazards identification
OSHA EMERGENCY OVERVIEW Solution Clear, Colorless to light yellow Odor unknown May be severely irritating to the eyes. Highly toxic by inhalation. Harmful if swallowed. Prolonged exposure may cause serious health effects. Harmful to aquatic organisms. May cause long-term adverse effects in the aquatic environment.
Potential health effects
The following summary is based upon available information about the individual ingredients of the mixture, or of the expected properties of the mixture. Flunixin meglumine is a potent non-narcotic, non-steroidal agent with pain killing, anti-inflammatory, and fever-reducing activity. Based on animal studies, flunixin meglumine may cause severe eye irritation or irreversible ocular effects. It may also cause irritation of the skin, mucous membranes, respiratory tract, and gastrointestinal tract. Repeated dermal contact to high concentrations may cause severe skin irritation. Prolonged inhalation may produce serious lung effects. Repeated ingestion or inhalation of high doses may cause internal bleeding, predominantly of the gastrointestinal tract. Propylene glycol is considered to be relatively non-toxic. It is a mild irritant to the eyes and has been reported to irritate the skin. It may cause skin sensitization resulting in allergic contact dermatitis in susceptible individuals. Inhalation exposure to saturated and supersaturated atmospheres of propylene glycol for prolonged periods of time produced no adverse effects. Propylene glycol may cause nervous system depression, acidosis, stupor, and seizures after chronic ingestion. LISTED CARCINOGENS